Wanjun Bai

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Major Depressive Disorder

Lymph Node Metastasis

Tyrosine Kinase

Top Venues

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wanjun Bai, Xue Sun, Bo Qiu, Caihui Guo, Haojing Song, Yiting Hu, Xueyuan Zhang, Peihua Yin, Xiaoru Wang, Zhanjun Dong
Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Drug design, development and therapy 18 (2024)
Haojing Song, Bo Qiu, Xue Sun, Caihui Guo, Yiting Hu, Wanjun Bai, Zhanjun Dong
Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects. Drug design, development and therapy 18 (2024)
Haojing Song, Bo Qiu, Xue Sun, Caihui Guo, Yiting Hu, Wanjun Bai, Zhanjun Dong
Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects. Drug design, development and therapy 18 (2024)
Wanjun Bai, Xue Sun, Bo Qiu, Caihui Guo, Haojing Song, Yiting Hu, Xueyuan Zhang, Peihua Yin, Xiaoru Wang, Zhanjun Dong
Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Drug design, development and therapy 18 (2024)
Wanjun Bai, Haojing Song, Yiting Hu, Xueyuan Zhang, Xiaoru Wang, Caihui Guo, Bo Qiu, Zhanjun Dong
Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions. Drug design, development and therapy 17 (2023)